Infinity Pharmaceuticals Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 30

Employees

  • Latest Deal Type
  • M&A

Infinity Pharmaceuticals General Information

Description

Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company dedicated to developing novel medicines for people with cancer. It combines scientific expertise with a passion for developing novel small molecule drugs that target disease pathways for potential applications in oncology. It is focused on advancing eganelisib, also known as IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma, or PI3K-gamma.

Contact Information

Website
www.infi.com
Formerly Known As
Discovery Partners International
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1100 Massachusetts Avenue
  • Cambridge, MA 02138
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 1100 Massachusetts Avenue
  • Cambridge, MA 02138
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Infinity Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Merger/Acquisition 01-Feb-2024 Completed Generating Revenue/Not Profitable
12. Bankruptcy: Admin/Reorg 02-Oct-2023 Completed Bankruptcy: Admin/Reorg
11. Merger/Acquisition 23-Feb-2023 Cancelled Generating Revenue
10. 2PO 29-Sep-2017 Completed Generating Revenue
9. PIPE 04-Apr-2017 Completed Generating Revenue
8. Merger/Acquisition 03-Sep-2014 Cancelled Generating Revenue
7. 2PO 21-Sep-2012 Completed Generating Revenue
6. PIPE 01-Jul-2012 Completed Generating Revenue
5. Reverse Merger 13-Sep-2006 $120M Completed Generating Revenue
4. Later Stage VC (Series C) 23-Dec-2004 $50M $120M Completed Generating Revenue
To view Infinity Pharmaceuticals’s complete valuation and funding history, request access »

Infinity Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company dedicated to developing novel medicines for p
Drug Discovery
Cambridge, MA
30 As of 2022

Pittsburgh, PA
 

Germantown, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Infinity Pharmaceuticals Competitors (44)

One of Infinity Pharmaceuticals’s 44 competitors is Sharp Therapeutics (Biotechnology), a Formerly VC-backed company based in Pittsburgh, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sharp Therapeutics (Biotechnology) Formerly VC-backed Pittsburgh, PA
Precigen Formerly VC-backed Germantown, MD
Sangamo Therapeutics Formerly VC-backed Richmond, CA
BioNTech Formerly VC-backed Mainz, Germany
XBiotech Corporation Austin, TX
You’re viewing 5 of 44 competitors. Get the full list »

Infinity Pharmaceuticals Patents

Infinity Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022125497-A1 Eganelisib for use in the treatment of pd-l1 negative cancer Inactive 08-Dec-2020
AU-2017281797-A1 Combination therapies Inactive 24-Jun-2016
CA-3028718-A1 Combination therapies Pending 24-Jun-2016
EP-3474856-A1 Combination therapies Active 24-Jun-2016
EP-3474856-B1 Combination therapies Active 24-Jun-2016 A61K39/395
To view Infinity Pharmaceuticals’s complete patent history, request access »

Infinity Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Infinity Pharmaceuticals Former Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advent Life Sciences Venture Capital Minority
Advent Venture Partners Venture Capital Minority
Aisling Capital Venture Capital Minority
Alexandria Venture Investments Venture Capital Minority
Amgen Ventures Corporate Venture Capital Minority
You’re viewing 5 of 25 investors. Get the full list »

Infinity Pharmaceuticals Acquisitions (1)

Infinity Pharmaceuticals’s most recent deal was a Merger/Acquisition with Discovery Partners International. The deal was made on 12-Sep-2006.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Discovery Partners International 12-Sep-2006 Merger/Acquisition Drug Discovery
To view Infinity Pharmaceuticals’s complete acquisitions history, request access »

Infinity Pharmaceuticals ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Infinity Pharmaceuticals’s complete esg history, request access »

Infinity Pharmaceuticals FAQs

  • When was Infinity Pharmaceuticals founded?

    Infinity Pharmaceuticals was founded in 1995.

  • Where is Infinity Pharmaceuticals headquartered?

    Infinity Pharmaceuticals is headquartered in Cambridge, MA.

  • What is the size of Infinity Pharmaceuticals?

    Infinity Pharmaceuticals has 30 total employees.

  • What industry is Infinity Pharmaceuticals in?

    Infinity Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Infinity Pharmaceuticals a private or public company?

    Infinity Pharmaceuticals is a Private company.

  • What is Infinity Pharmaceuticals’s current revenue?

    The current revenue for Infinity Pharmaceuticals is .

  • How much funding has Infinity Pharmaceuticals raised over time?

    Infinity Pharmaceuticals has raised $150M.

  • Who are Infinity Pharmaceuticals’s investors?

    Advent Life Sciences, Advent Venture Partners, Aisling Capital, Alexandria Venture Investments, and Amgen Ventures are 5 of 25 investors who have invested in Infinity Pharmaceuticals.

  • Who are Infinity Pharmaceuticals’s competitors?

    Sharp Therapeutics (Biotechnology), Precigen, Sangamo Therapeutics, BioNTech, and XBiotech are some of the 44 competitors of Infinity Pharmaceuticals.

  • When was Infinity Pharmaceuticals acquired?

    Infinity Pharmaceuticals was acquired on 01-Feb-2024.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process